Tech Company Financing Transactions
NOWATCH Funding Round
NOWATCH closed a $8.7 million Series A venture capital round on 6/15/2022. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/15/2022
Transaction Type
Venture Equity
Amount
$8,700,000
Round
Series A
Investors
private investors (Lead Investor) (Chris Hall)
Proceeds Purpose
With this funding, NOWATCH will expand its marketing reach, scale research & development efforts, and grow its internal team.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Prinsengracht 769
Amsterdam, 1017 JZ
The Netherlands
Amsterdam, 1017 JZ
The Netherlands
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
NOWATCH is a health innovation company with a mission to help people navigate the increasingly fast-paced world of technology. Our flagship product, the NOWATCH Awareable, is the first wearable device to measure a cortisol proxy, predicting stress response and restoring balance for complete mind and body wellbeing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hylke Muntinga
Chief Operating Officer
Charley Dirksen
President
Timothée Manschot
VP - Bus. Development
Michiel de Koning
Browse more venture capital transactions:
Prev: 6/15/2022: Mosaic Biosciences venture capital transaction
Next: 6/15/2022: UpGrad venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs